NCT07237100
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07237100
Title Mirdametinib in Patients With Advanced NF1-mutant Melanoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Kevin Kim, MD
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
California Pacific Medical Center - Sutter Health RECRUITING San Francisco California 94115 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field